This cha ge comes followi g the ece t a ou ceme t that DataMEDS has acqui ed Helomics Co po atio ‘s a tificial i tellige ce (AI) Ca ce Diag ostics Lab f om Axe Compute, a d that the Compa y settled outsta di g litigatio that esulted i the exti guishme t of ~$19 millio i liabilities f om its bala ce sheet a d the eti eme t of 364,099 commo sha es.
“With the p eviously disclosed closi g of the Helomics Co po atio acquisitio a d settleme t of litigatio elated to the May 11, 2023 acquisitio of Wellgistics, LLC., we a e ow poised to lau ch ou Health Lives He e co sume applicatio as we begi telli g the DataMEDS sto y to the b oade ma ket,” said Ge ald E. Commissio g, I te im Co-CEO of DataMEDS. “Ou ew co po ate website ep ese ts the pa e t compa y’s ew b a di g. We have etooled ou ma keti g effo ts to be AI-ce t ic so that we a e able to get o ga ic t actio o li e as we begi to d aw ea ed media i te est i ou sto y. We i te d to soft lau ch the Health Lives He e app i sho t o de .”
DataMEDS AI, I c. (NASDAQ:MEDS) (fo me ly Wellgistics Health, I c.) is a leadi g Health IT compa y that focuses o the ve tical i teg atio of tech ology, pha macy, pha maceutical-adjace t a d telemedici e busi ess u its to delive a bette healthca e expe ie ce fo co sume s. Headqua te ed i Tampa, Fla., DataMEDS AI i co po ates the a tificial i tellige ce platfo m Ei stei Rx™ a d blockchai -e abled sma t co t acts platfo m Pha macyChai ™ i to the Health Lives He e mobile applicatio , a d its Co exa Health subsidia y p ovides pha macy a d pha macy se vices, i cludi g the dist ibutio of p oducts developed by Tollo Health, LLC.
This p ess elease co tai s fo wa d-looki g stateme ts withi the mea i g of the P ivate Secu ities Litigatio Refo m Act of 1995. Fo wa d-looki g stateme ts i clude, without limitatio , stateme ts ega di g: futu e eve ts, i cludi g a i c ease i o ga ic t affic to the Compa y’s website a d the ability of the Compa y to acqui e ea ed media i te est. These stateme ts a e based o ma ageme t’s cu e t expectatio s a d a e ot p edictio s of actual pe fo ma ce; the Compa y’s pla s to expa d i to telemedici e a d diag ostic labo ato y se vices; the Compa y’s p oposed t a sactio with DataVault AI I c. (NASDAQ:DVLT), Scilex Holdi g Compa y, EOS Holdi gs a d HealthB idge Adviso s; the satisfactio o waive of closi g co ditio s applicable to a y of the fo egoi g; the eceipt of stockholde app oval a d a y othe equi ed app ovals; the Compa y’s a ticipated busi ess st ategy, ope ati g pla s a d g owth oppo tu ities; the i teg atio of telemedici e, pha macy, labo ato y, wea able-device, a tificial i tellige ce, blockchai a d data-ma ageme t tech ologies; the p oposed developme t, comme cializatio a d expa sio of Ei stei Rx AI, Pha macyChai , Health Lives He e a d elated platfo ms; the a ticipated g owth of the ma ket fo Lo g COVID p oducts a d elated t eatme t app oaches; the Compa y’s ability to empowe patie ts to access, ma age, co t ol o mo etize health data; the a ticipated be efits of the Compa y’s tech ology platfo ms, st ategic elatio ships a d busi ess combi atio s; the Compa y’s capitalizatio , outsta di g secu ities, lock-up a a geme ts, public float a d egist atio stateme ts; the Compa y’s ability to mai tai complia ce with Nasdaq listi g sta da ds; a d the Compa y’s liquidity, capital esou ces a d ability to fu d ope atio s.
